Dear editor,

I read with great interest in the previous issue of the *American Journal of Men's Health* the article "Comparison of *Serenoa repens* With Tamsulosin in the Treatment of Benign Prostatic Hyperplasia: A Systematic Review and Meta-Analysis" ([@bibr4-1557988320936897]).

First of all, I have benefited from the article that informs urologists about phytotherapy in the treatment of men with lower urinary tract symptoms (LUTS)/benign prostatic hyperplasia (BPH). In vitro studies have demonstrated that *S. repens* has antiandrogenic, antiproliferative, and anti-inflammatory effects ([@bibr3-1557988320936897]). Nevertheless I have some concerns about treatment of LUTS with *S. repens*. One-year follow-up Saw Palmetto for Treatment of Enlarged Prostates (STEP) study ([@bibr1-1557988320936897]) and 18-months follow-up Complementary and Alternative Medicine for Urological Symptoms (CAMUS) study ([@bibr2-1557988320936897]) have showed that saw palmetto did not demonstrate superiority over placebo in men with BPH who had LUTS. Moreover, a prospective, 1-year trial using saw palmetto versus finasteride in the treatment of category III prostatitis showed that patients treated with saw palmetto had no appreciable long-term improvement ([@bibr5-1557988320936897]). *It should be noted that although S. repens is used in many countries for the treatment of BPH, it is not currently recommended as equivalent to alpha-blockers in any guideline.*
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